Erik A. Williams

2.2k total citations
57 papers, 808 citations indexed

About

Erik A. Williams is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erik A. Williams has authored 57 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 16 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erik A. Williams's work include Cancer Genomics and Diagnostics (15 papers), Sarcoma Diagnosis and Treatment (7 papers) and Glioma Diagnosis and Treatment (5 papers). Erik A. Williams is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Sarcoma Diagnosis and Treatment (7 papers) and Glioma Diagnosis and Treatment (5 papers). Erik A. Williams collaborates with scholars based in United States, Germany and Italy. Erik A. Williams's co-authors include David N. Louis, Jantima Tanboon, Robin T. Aplin, Peter N. Taylor, Juhani Huuskonen, Harry L. Anderson, Garry Rumbles, Daniel P. Cahill, Tareq A. Juratli and Jeffrey S. Ross and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Erik A. Williams

54 papers receiving 801 citations

Peers

Erik A. Williams
Erik A. Williams
Citations per year, relative to Erik A. Williams Erik A. Williams (= 1×) peers Summer L. Gibbs‐Strauss

Countries citing papers authored by Erik A. Williams

Since Specialization
Citations

This map shows the geographic impact of Erik A. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Williams more than expected).

Fields of papers citing papers by Erik A. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Williams. The network helps show where Erik A. Williams may publish in the future.

Co-authorship network of co-authors of Erik A. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Williams. A scholar is included among the top collaborators of Erik A. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Williams. Erik A. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mata, Douglas A., Jessica Lee, Vignesh Shanmugam, et al.. (2024). Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results. Histopathology. 84(7). 1224–1237. 5 indexed citations
2.
Kato, Shumei, Mina Nikanjam, Aditya Shreenivas, et al.. (2024). On the right TRACK: Providing comprehensive genomic profiling (CGP) and molecular tumor board (MTB) for patients (pts) with rare cancers.. Journal of Clinical Oncology. 42(16_suppl). 3127–3127. 2 indexed citations
3.
Williams, Erik A., Fardous F. El‐Senduny, Douglas A. Mata, et al.. (2024). Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma. The American Journal of Surgical Pathology. 48(6). 699–707. 3 indexed citations
4.
Tsai, Harrison, Mark F Sabbagh, Meagan Montesion, et al.. (2024). Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. Modern Pathology. 37(7). 100509–100509. 7 indexed citations
5.
Williams, Erik A., Priscilla K. Brastianos, Hiroaki Wakimoto, et al.. (2023). A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta Neuropathologica. 146(3). 515–525. 16 indexed citations
6.
Williams, Erik A., Radwa Sharaf, Brennan Decker, et al.. (2020). CDKN2C -Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53 / RB1 –Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion. JCO Precision Oncology. 4(4). 955–971. 10 indexed citations
7.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations. Modern Pathology. 33(12). 2397–2406. 20 indexed citations
8.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles. Modern Pathology. 33(8). 1466–1474. 32 indexed citations
9.
Williams, Erik A., Meagan Montesion, Radwa Sharaf, et al.. (2020). CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma. Modern Pathology. 33(12). 2614–2625. 9 indexed citations
10.
Williams, Erik A., Meagan Montesion, Brian M. Alexander, et al.. (2020). CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features. Modern Pathology. 34(2). 358–370. 12 indexed citations
11.
Williams, Erik A., Sandro Santagata, Hiroaki Wakimoto, et al.. (2020). Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathologica Communications. 8(1). 171–171. 60 indexed citations
12.
Williams, Erik A., Natalie Danziger, Meagan Montesion, et al.. (2020). Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms. Journal of the American Academy of Dermatology. 84(4). 1069–1071. 5 indexed citations
13.
Williams, Erik A., Hiroaki Wakimoto, Ganesh M. Shankar, et al.. (2020). Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features. Acta Neuropathologica. 140(1). 89–93. 30 indexed citations
14.
Miller, Julie J., Franziska Loebel, Tareq A. Juratli, et al.. (2019). Accelerated progression of IDH mutant glioma after first recurrence. Neuro-Oncology. 21(5). 669–677. 37 indexed citations
15.
Marchione, Dylan M., Angela N. Viaene, Mariarita Santi, et al.. (2019). Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss. Modern Pathology. 32(10). 1434–1446. 32 indexed citations
16.
Williams, Erik A., et al.. (2019). 819 Extragenital lichen sclerosus is an immune-related adverse event with nivolumab. Journal of Investigative Dermatology. 139(5). S141–S141.
17.
Williams, Erik A., Julie J. Miller, Shilpa S. Tummala, et al.. (2018). TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations. Acta Neuropathologica Communications. 6(1). 106–106. 18 indexed citations
18.
Chen, Ching‐Jen, et al.. (2014). Histiocytic sarcoma of the cavernous sinus: case report and literature review. Brain Tumor Pathology. 32(1). 66–71. 18 indexed citations
19.
Zhao, Liang, Weijie Li, Thomas D. Griffin, et al.. (2009). Srcasm Inhibits Fyn-Induced Cutaneous Carcinogenesis with Modulation of Notch1 and p53. Cancer Research. 69(24). 9439–9447. 44 indexed citations
20.
Williams, Erik A. & Dennis E. Jelinski. (1996). On using the NOAA AVHRR Experimental calibrated biweekly Global Vegetation Index. Photogrammetric Engineering & Remote Sensing. 62(8). 959–960. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026